EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Unveiling the Secrets of Acinetobacter baumannii: Resistance, Current Treatments, and Future Innovations

Andrea Marino iD, Egle Augello iD, Stefano Stracquadanio iD, Carlo Maria Bellanca iD, Federica Cosentino, Serena Spampinato, Giuseppina Cantarella iD, Renato Bernardini, Stefania Stefani iD, Bruno Cacopardo, Giuseppe Nunnari iD

International Journal of Molecular Sciences · 21.06.2024 · 25 (13) · 6814

DOI: 10.3390/ijms25136814 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 21.06.2024. Verfasst von Andrea Marino und 10 weiteren Autor:innen. Beteiligte Einrichtung: Unit of Infectious Diseases, Department of Clinical and Experimental Medicine, University of Catania, ARNAS Garibaldi Hospital, 95122 Catania, Italy. Hauptthemen laut MEDLINE: Acinetobacter baumannii, Anti-Bacterial Agents, Acinetobacter Infections. Die Arbeit wurde bisher 85-mal zitiert (Crossref) und nennt 132 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acinetobacter baumannii represents a significant concern in nosocomial settings, particularly in critically ill patients who are forced to remain in hospital for extended periods. The challenge of managing and preventing this organism is further compounded by its increasing ability to develop resistance due to its extraordinary genomic plasticity, particularly in response to adverse environmental conditions. Its recognition as a significant public health risk has provided a significant impetus for the identification of new therapeutic approaches and infection control strategies. Indeed, currently used antimicrobial agents are gradually losing their efficacy, neutralized by newer and newer mechanisms of bacterial resistance, especially to carbapenem antibiotics. A deep understanding of the underlying molecular mechanisms is urgently needed to shed light on the properties that allow A. baumannii enormous resilience against standard therapies. Among the most promising alternatives under investigation are the combination sulbactam/durlobactam, cefepime/zidebactam, imipenem/funobactam, xeruborbactam, and the newest molecules such as novel polymyxins or zosurabalpin. Furthermore, the potential of phage therapy, as well as deep learning and artificial intelligence, offer a complementary approach that could be particularly useful in cases where traditional strategies fail. The fight against A. baumannii is not confined to the microcosm of microbiological research or hospital wards; instead, it is a broader public health dilemma that demands a coordinated, global response.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acinetobacter baumanniiAnti-Bacterial AgentsAcinetobacter InfectionsHumansDrug Resistance, Multiple, BacterialDrug Resistance, Bacterial

Stichwörter der Autor:innen

Acinetobacter baumanniiAcinetobacter infectionsAcinetobacter treatmentsCRABMDR Acinetobactercefiderocoleravacycline

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Unit of Infectious Diseases, Department of Clinical and Experimental Medicine, University of Catania, ARNAS Garibaldi Hospital, 95122 Catania, Italy.
  • Department of Biomedical and Biotechnological Science, Section of Pharmacology, University of Catania, 95123 Catania, Italy.
  • Clinical Toxicology Unit, University Hospital of Catania, 95123 Catania, Italy.
  • Department of Biomedical and Biotechnological Sciences, Section of Microbiology, University of Catania, Via Santa Sofia 97, 95123 Catania, Italy.

ORCID-Profile: Andrea Marino, Egle Augello, Stefano Stracquadanio, Carlo Maria Bellanca, Giuseppina Cantarella, Stefania Stefani, Giuseppe Nunnari

Zitieren

APA

Marino, A., Augello, E., Stracquadanio, S., Bellanca, C. M., Cosentino, F., Spampinato, S., Cantarella, G., Bernardini, R., Stefani, S., Cacopardo, B., & Nunnari, G. (2024). Unveiling the Secrets of Acinetobacter baumannii: Resistance, Current Treatments, and Future Innovations. International Journal of Molecular Sciences, 25(13), 6814. https://doi.org/10.3390/ijms25136814

Vancouver

Marino A, Augello E, Stracquadanio S, Bellanca CM, Cosentino F, Spampinato S, et al. Unveiling the Secrets of Acinetobacter baumannii: Resistance, Current Treatments, and Future Innovations. International Journal of Molecular Sciences. 2024;25(13):6814. doi:10.3390/ijms25136814

BibTeX
@article{Marino2024,
  author = {Marino, Andrea and Augello, Egle and Stracquadanio, Stefano and Bellanca, Carlo Maria and Cosentino, Federica and Spampinato, Serena and Cantarella, Giuseppina and Bernardini, Renato and Stefani, Stefania and Cacopardo, Bruno and Nunnari, Giuseppe},
  title = {Unveiling the Secrets of Acinetobacter baumannii: Resistance, Current Treatments, and Future Innovations},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  volume = {25},
  number = {13},
  pages = {6814},
  doi = {10.3390/ijms25136814}
}
Kostenlos starten →